User:Keilana/Cochrane women's health

General (Gynecologic oncology)

 * Perioperative enhanced recovery programmes for gynaecological cancer patients Gynecologic oncology
 * Patient‐reported outcome measures for follow‐up after gynaecological cancer treatment
 * Robot‐assisted surgery in gynaecology Hysterectomy Sacrocolpopexy
 * Vaginal dilator therapy for women receiving pelvic radiotherapy Vaginal dilation Endometrial cancer Cervical cancer Vaginal cancer
 * Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies Cervical cancer Endometrial cancer Ovarian cancer
 * Exenterative surgery for recurrent gynaecological malignancies Pelvic exenteration Cervical cancer Endometrial cancer Vaginal cancer Vulvar cancer
 * Centralisation of services for gynaecological cancer Gynecologic oncology
 * Interventions for psychosexual dysfunction in women treated for gynaecological malignancy Gynecologic oncology Psychosexual dysfunction

Ovarian cancer

 * Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer Ovarian cancer Epithelial ovarian cancer
 * Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer Ovarian cancer
 * Antigen‐specific active immunotherapy for ovarian cancer Ovarian cancer
 * Evaluation of follow‐up strategies for patients with epithelial ovarian cancer following completion of primary treatment Ovarian cancer
 * Effectiveness of different treatment modalities for the management of adult‐onset granulosa cell tumours of the ovary (primary and recurrent) Granulosa cell tumor Ovarian cancer
 * Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer Ovarian cancer
 * Perioperative nutrition interventions for women with ovarian cancer Ovarian cancer
 * Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility Ovarian cancer Assisted reproductive technology
 * Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer Ovarian cancer
 * Maintenance chemotherapy for ovarian cancer Ovarian cancer
 * Interferon after surgery for women with advanced (Stage II‐IV) epithelial ovarian cancer Ovarian cancer
 * Interval debulking surgery for advanced epithelial ovarian cancer Ovarian cancer
 * Laparoscopy versus laparotomy for FIGO stage I ovarian cancer Ovarian cancer
 * Surgical cytoreduction for recurrent epithelial ovarian cancer Ovarian cancer
 * Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma Ovarian cancer
 * Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer Ovarian cancer
 * Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer Ovarian cancer
 * Epidermal growth factor receptor blockers for the treatment of ovarian cancer Ovarian cancer
 * Angiogenesis inhibitors for the treatment of ovarian cancer Ovarian cancer
 * Optimal primary surgical treatment for advanced epithelial ovarian cancer Ovarian cancer
 * Ultra‐radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer Ovarian cancer
 * Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease Ovarian cancer
 * Interventions for the treatment of borderline ovarian tumours Ovarian cancer
 * Palliative surgery versus medical management for bowel obstruction in ovarian cancer Ovarian cancer
 * Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer Ovarian cancer
 * Tamoxifen for relapse of ovarian cancer Ovarian cancer
 * Management of drainage for malignant ascites in gynaecological cancer Gynecologic oncology Ovarian cancer
 * Topotecan for ovarian cancer Ovarian cancer
 * Chemotherapy for advanced ovarian cancer Ovarian cancer

Cervical cancer

 * Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia Cervical cancer Cervical intraepithelial neoplasia
 * Palliative interventions for controlling vaginal bleeding in advanced cervical cancer Vaginal bleeding Cervical cancer
 * Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer Cervical cancer
 * Follow‐up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test LLETZ Cervical intraepithelial neoplasia Cervical cancer
 * Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer Cervical cancer
 * High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer Cervical cancer
 * Surgical treatment of stage IA2 cervical cancer Cervical cancer
 * Non‐steroidal anti‐inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia Cervical cancer Cervical intraepithelial neoplasia
 * Surgery for cervical intraepithelial neoplasia Cervical cancer Cervical intraepithelial neoplasia
 * Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia Cervical cancer Cervical intraepithelial neoplasia
 * Follow‐up protocols for women with cervical cancer after primary treatment Cervical cancer
 * Retinoids for preventing the progression of cervical intra‐epithelial neoplasia Cervical cancer Cervical intraepithelial neoplasia
 * Pre‐treatment surgical para‐aortic lymph node assessment in locally advanced cervical cancer Cervical cancer
 * Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions Human papillomavirus Cervical cancer
 * Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix Cervical cancer
 * Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer Cervical cancer
 * Chemotherapy for metastatic and recurrent cervical cancer Cervical cancer
 * Pain relief for women with cervical intraepithelial neoplasia undergoing colposcopy treatment Cervical cancer Cervical intraepithelial neoplasia Colposcopy
 * Adjuvant platinum‐based chemotherapy for early stage cervical cancer Cervical cancer
 * Radiotherapy and chemoradiation after surgery for early cervical cancer Cervical cancer
 * Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cervical cancer
 * Neoadjuvant chemotherapy for locally advanced cervix cancer Cervical cancer
 * Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix Cervical cancer
 * Collection devices for obtaining cervical cytology samples Cervical cancer Cervical cancer screening
 * Interventions targeted at women to encourage the uptake of cervical screening Cervical cancer Cervical cancer screening
 * Interventions for encouraging sexual behaviours intended to prevent cervical cancer Cervical cancer
 * Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma Cervical cancer
 * Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta‐analysis Cervical cancer

Endometrial cancer

 * Lymphadenectomy for the management of endometrial cancer Endometrial cancer
 * Adjuvant chemotherapy for advanced endometrial cancer Endometrial cancer
 * Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma Endometrial cancer
 * Laparoscopy versus laparotomy for the management of early stage endometrial cancer Endometrial cancer
 * Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma Endometrial cancer
 * Adjuvant radiotherapy for stage I endometrial cancer Endometrial cancer
 * Adjuvant chemotherapy for endometrial cancer after hysterectomy Endometrial cancer
 * Adjuvant progestagens for endometrial cancer Endometrial cancer
 * Hormonal therapy in advanced or recurrent endometrial cancer Endometrial cancer

Vulvar cancer

 * Medical interventions for high-grade vulval intraepithelial neoplasia Vulvar cancer
 * Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer Vulvar cancer
 * Surgical interventions for high‐grade vulval intraepithelial neoplasia Vulvar cancer Vulval intraepithelial neoplasia
 * Interventions for the treatment of Paget's disease of the vulva Paget's disease of the vulva Vulvar cancer
 * Primary groin irradiation versus primary groin surgery for early vulvar cancer Vulvar cancer
 * Surgical interventions for early squamous cell carcinoma of the vulva Vulvar cancer
 * Chemoradiation for advanced primary vulval cancer Vulvar cancer

Gestational trophoblastic disease

 * Combination chemotherapy for primary treatment of high‐risk gestational trophoblastic tumour Gestational trophoblastic disease
 * Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia Gestational trophoblastic disease
 * Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia Hydatidiform mole Gestational trophoblastic disease
 * First‐line chemotherapy in low‐risk gestational trophoblastic neoplasia Gestational trophoblastic disease

Symptoms

 * Palliative interventions for controlling vaginal bleeding in advanced cervical cancer Vaginal bleeding Cervical cancer

Treatments

 * Follow‐up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test LLETZ Cervical intraepithelial neoplasia Cervical cancer
 * Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer Cervical cancer Hysterectomy
 * Interventions for reducing anxiety in women undergoing colposcopy Colposcopy